Frank Yocca, Chief Scientific Officer at BioXcel Therapeutics, Inc. (BTAI), bought 13,094 shares at $8.67 ($114K) on 2019-08-13, disclosed to the SEC on 2019-08-14.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $8.67 | 6,547 | $57K | 50.0% |
| 2 | $8.67 | 6,547 | $57K | 50.0% |
| Total | $8.67 avg | 13,094 | $114K | 100% |
| Filing → |
| BTAI | SELL | 2024-10-03 | $4K | — | Filing → |
| BTAI | SELL | 2024-09-17 | $245 | — | Filing → |
| BTAI | SELL | 2024-06-18 | $476 | — | Filing → |